Agape ATP Corp (ATPC): Nasdaq/NYSE listing notice — Agape ATP receives Nasdaq MVLS deficiency notice; 180 days to regain compliance

Agape ATP Corp

Nasdaq notified Agape ATP on March 28, 2024 that MVLS fell below $35M minimum from Feb 14 to Mar 27, 2024.
Company cited non-compliance with Listing Rules 5550(b)(1) and 5550(b)(3).
Compliance period ends September 24, 2024; can cure if MVLS closes at $35M+ for 10 consecutive days.
Company evaluating options but cautions no assurance of regaining compliance.
Failure to cure may result in delisting from Nasdaq Capital Market.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Agape ATP Corp received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(1), 5550(b)(3)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(1), 5550(b)(3)

Exact text from the filing

March 28, 2024, Agape ATP Corporation (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the Market Value of Listed Securities (“MVLS”) of the Company for the period from February 14, 2024 to March 27, 2024, the Company no longer meets the listing requirement of Nasdaq under Nasdaq Listing Rules 5550(b)(1) and 5550(b)(3), to maintain a minimum MVLS of $35 million. Nasdaq has provided the Company with an 180 calendar days compliance period, or until September 24, 2024, in which to regain compliance wi

View on SEC.gov

Browse all listing & compliance notices →

Agape ATP Corp filing history →

Source: SEC EDGAR

accession 0001493152-24-013182

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.